Early in the morning in Yamoussoukro, Côte d'Ivoire, workers load truck with bales of mosquito nets for delivery to nearby communities. Each of white bale contains 50 insecticide-treated nets which will be distributed in the region to help protect to families against malaria.

The Global Fund plays a leading role in global markets for medicines and technologies that prevent, diagnose and treat HIV, tuberculosis and malaria. Every year, roughly half of the Global Fund’s investments – about US$2 billion – is used to procure these key medicines and health products, ensuring they are available to those who need them most and accelerating the end of the epidemics.

The procurement and supply management of health products are fundamental to the performance of Global Fund-supported programs. Yet we face challenges such as stock-outs, quality issues and insufficient supply chains, which put lives at risk and endanger the investment and progress we have made against the three diseases.

Our approach to supplying critical medicines and health products focuses across the entire supply chain, from sourcing and procurement to distribution of medicines to patients. We are committed to ensuring that our partners managing Global Fund-financed programs achieve the best value for their investment and have the tools and information to:

Access optimal, quality-assured medicines and health products
Obtain the best prices and conditions available
Adequately plan and manage the selection, purchase, delivery, warehousing and distribution of products
Work effectively with partners to improve their supply chains
Because our work and our grants support public health efforts in countries and communities around the world, the collective purchasing power of our grants has an impact on the market for and price of many health products.